<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02705573</url>
  </required_header>
  <id_info>
    <org_study_id>2021/2014</org_study_id>
    <nct_id>NCT02705573</nct_id>
  </id_info>
  <brief_title>Effects of Mannitol on Delayed Graft Function After Cadaveric Renal Transplantation</brief_title>
  <official_title>Effects of Mannitol on Delayed Graft Function After Cadaveric Renal Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study we want to evaluate the effect of mannitol on postoperative renal biomarkers in
      patient receiving cadaveric renal transplantation. Furthermore we want to evaluate the effect
      of mannitol on perioperative redox status in patients receiving renal transplantation using
      the oxidation-reduction potentials assessed with the RedoxSYSÂ®system.

      We are planning to perform a double-blind randomized controlled trial. In the study, mannitol
      20% with a dose of 1g / kg / BW (5 ml / kg / BW) will be compared to placebo with NaCl 0.9%
      in the dose of 5 ml / kg / BW. Patients will be randomized to receive either the mannitol or
      NaCl. The follow-up of the study is 24 hours. The following biomarkers will be determined
      befor induction of anesthesia and 24 hours after administration of study medication: CCL2,
      CHI3LI, GH, HGF, MMP1, MMP8, Tie2, TNF-R1, VCAM-1, KIM-1, Cystatin C, FGF23, IGFB7, NGAL and
      IL 18.

      Furthermore we want to perform sORP and cORP before induction of anesthesia, just before
      bolus of mannitol, 5 min after bolus of mannitol and after operation in anesthetic recovery
      room.

      Data will be collected, compared and published at the end of the study. It is planned to
      include a total of 34 patients in the study.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">July 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>renal biomark</measure>
    <time_frame>24 hours</time_frame>
    <description>The BM-panel includes the following analytes: CCL2, CHI3LI, GH, HGF, MMP1, MMP8, Tie2, TNF-R1, VCAM-1, KIM-1, Cystatin C and Endostatin. Additionally, the BM-panel can be extended for measurement of FGF23, IGFB7, NGAL and IL 18.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>renal function parameter</measure>
    <time_frame>24 hours</time_frame>
    <description>creatinine, blood urea, nitrogen, urinary output, potassium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>oxidation-reduction potential (ORP) of mannitol</measure>
    <time_frame>24 hours</time_frame>
    <description>static ORP (sORP), capacity ORP (cORP)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">34</enrollment>
  <condition>Kidney Transplantation, Mannitol</condition>
  <arm_group>
    <arm_group_label>Mannitol 20%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mannitol 1g/ kg BW</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nacl 0.9%</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>NaCl 0.9% 5ml/ kg BW</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mannitol</intervention_name>
    <description>In the study, mannitol 20% with a dose of 1g / kg / BW (5 ml / kg / BW) will be compared to placebo with NaCl 0.9% in the dose of 5 ml / kg / BW. The study medication will be administered immediately before organ reperfusion. The follow-up of the study is 24 hours.</description>
    <arm_group_label>Mannitol 20%</arm_group_label>
    <arm_group_label>Nacl 0.9%</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: all patients with end stage renal diseases -

        Exclusion Criteria: Patients younger than 18 years of age or older than 80, alergy to
        mannitol, Pregnancy, Breast-feed
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Samir Sljivic, Dr.</last_name>
    <phone>+4314040041020</phone>
    <email>samir.sljivic@meduniwien.ac.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical University Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samir Sljivic, Dr</last_name>
      <phone>004314040041020</phone>
      <email>samir.sljivic@meduniwien.ac.at</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2016</study_first_submitted>
  <study_first_submitted_qc>March 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2016</study_first_posted>
  <last_update_submitted>May 14, 2018</last_update_submitted>
  <last_update_submitted_qc>May 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Samir Sljivic</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delayed Graft Function</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mannitol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

